Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Biomolecules ; 9(8)2019 08 03.
Artículo en Inglés | MEDLINE | ID: mdl-31382562

RESUMEN

The aim of the present experiment is to study the effects of oral ingestion of a mixture of two probiotic bacteria on sperm quality and progenies. Three homogeneous groups of juvenile zebrafish were created. Once having reached adulthood (3 months postfertilization; mpf), each group received different feeding regimens: a standard diet (control), a maltodextrin-supplemented diet (vehicle control), or a probiotic-supplemented diet (a mixture (1:1) of Lactobacillus rhamnosus CECT8361 and Bifidobacterium longum CECT7347). The feeding regime lasted 4.5 months. Growth parameters (weight and length) were determined at 3, 5, and 7.5 mpf. Sperm motility was evaluated using computer-assisted sperm analysis at 5 and 7.5 mpf. Progeny survival, hatching rate, and malformation rate were also evaluated. Results showed that probiotic-supplemented diet improved growth parameters compared with the standard diet. The highest percentage of motile spermatozoa was reported in the probiotic-fed group. Concomitantly, the percentage of fast sperm subpopulation was significantly lower in samples derived from control males. Furthermore, there was a significant difference in progeny survival between the probiotic-fed group and the control group at three developmental times (24 hours postfertilization (hpf), 5 days postfertilization (dpf) and 7 dpf). In conclusion, in zebrafish, prolonged ingestion of a mixture of Lactobacillus rhamnosus CECT8361 and Bifidobacterium longum CECT7347 has positive effects on growth, sperm quality, and progeny survival.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/efectos adversos , Suplementos Dietéticos/efectos adversos , Motilidad Espermática/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Pez Cebra/fisiología , Animales , Antiinflamatorios/efectos adversos , Antioxidantes/farmacología , Bifidobacterium longum/efectos de los fármacos , Bifidobacterium longum/crecimiento & desarrollo , Lacticaseibacillus rhamnosus/efectos de los fármacos , Lacticaseibacillus rhamnosus/crecimiento & desarrollo , Masculino
2.
Food Funct ; 10(8): 4975-4984, 2019 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-31343650

RESUMEN

The aim of this study was to investigate the characteristics of a novel selenium-enriched Bifidobacterium longum DD98 (Se-B. longum DD98) supplement food and its repairing effects on the intestinal ecology of mammals. We assessed the growth, Se accumulation, and Se biotransformation of B. longum DD98 and its effects on antibiotic-induced intestinal dysbacteriosis in mice. The viable bacterial count at the end of fermentation was not significantly affected by the presence of Se. Bifidobacterium longum DD98 took up inorganic Se from the medium and biotransformed it into Se-containing proteins and selenoamino acids. The dominant Se species was selenomethionine (SeMet), which comprised 87% of the total Se in Se-B. longum DD98. Furthermore, Se-B. longum DD98 showed better regulation of the disrupted intestinal microbiota back to normal levels and repaired damaged colon tissues compared to the natural recovery and B. longum DD98 treatments. These findings suggest that B. longum DD98 efficiently biotransformed inorganic Se into more bioactive organic Se forms and may have therapeutic potential for the restoration of antibiotic-induced intestinal dysbacteriosis.


Asunto(s)
Antibacterianos/efectos adversos , Bifidobacterium longum/química , Disbiosis/tratamiento farmacológico , Intestinos/microbiología , Probióticos/administración & dosificación , Selenio/análisis , Animales , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Bifidobacterium longum/crecimiento & desarrollo , Bifidobacterium longum/metabolismo , Biotransformación , Disbiosis/etiología , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Intestinos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos ICR , Probióticos/análisis , Selenio/metabolismo
3.
Benef Microbes ; 10(5): 569-577, 2019 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-30964326

RESUMEN

Intestinal mucositis is a frequent side effect in cancer patients who are treated with chemotherapy. There are no effective treatment strategies to date. To find a novel way to alleviate mucositis, the effects of selenium-enriched Bifidobacterium longum (Se-B. longum) in preventing irinotecan (CPT-11)-induced intestinal mucositis in a mouse model were investigated. We tested the ability of Se-B. longum (Se 0.6 mg/kg, 5×108 cfu/mice) to reduce small intestinal mucositis induced by CPT-11 (75 mg/kg, daily) injected intraperitoneally for four consecutive days in mice. Se-B. longum significantly decreased mortality induced by CPT-11 from 71.4% to 16.7%. CPT-11 induced body weight loss, which was alleviated by preventative and simultaneous administration of Se-B. longum. Se-B. longum significantly decreased the severity of diarrhoea from 11 to 4% compared to the CPT-11 group. Inflammation, including intestinal shortening and upregulation of tumour necrosis factor-α and interleukin-1ß induced by CPT- 11, were prevented by Se-B. longum. Se-B. longum is effective in preventing small intestinal mucositis induced by CPT-11 and therefore has potential to be used clinically by cancer patients.


Asunto(s)
Antioxidantes/metabolismo , Bifidobacterium longum/crecimiento & desarrollo , Bifidobacterium longum/metabolismo , Irinotecán/toxicidad , Mucositis/prevención & control , Probióticos/administración & dosificación , Selenio/metabolismo , Animales , Modelos Animales de Enfermedad , Irinotecán/administración & dosificación , Ratones , Mucositis/inducido químicamente , Mucositis/patología , Análisis de Supervivencia , Resultado del Tratamiento
4.
Int J Food Sci Nutr ; 70(2): 182-194, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30160546

RESUMEN

In this study, we first investigated the survival of three probiotic strains, individually and combined with acerola by-product during simulated gastrointestinal conditions. Next, we investigated the effects of acerola by-product combined with Bifidobacterium longum BB-46 on a gut microbiota model (SHIME®). Chemical composition, total phenolic compounds, antioxidant activity of the acerola by-product and microbial counts, denaturing gradient gel electrophoresis (DGGE), ammonium ions ( NH4+ ) and short-chain fatty acids (SCFAs) analysis of the SHIME® samples were performed. Acerola by-product revealed high protein and fibre, reduced lipid contents, and showed to be an excellent source of total phenolic compounds with high in vitro antioxidant activity. A decreased amount of NH4+ in the ascending colon and an increase (p < .05) in SCFAs were observed in the three regions of colon during treatment with BB-46 and acerola by-product. BB-46 combined with acerola by-product showed positive effects on the gut microbiota metabolism in SHIME® model.


Asunto(s)
Antioxidantes/farmacología , Bifidobacterium longum , Colon/metabolismo , Microbioma Gastrointestinal , Malpighiaceae/química , Fenoles/farmacología , Probióticos , Compuestos de Amonio/metabolismo , Antioxidantes/análisis , Bifidobacterium longum/crecimiento & desarrollo , Bifidobacterium longum/metabolismo , Colon/efectos de los fármacos , Grasas de la Dieta/análisis , Fibras de la Dieta/análisis , Proteínas en la Dieta/análisis , Frutas/química , Humanos , Valor Nutritivo , Fenoles/análisis , Preparaciones de Plantas/química , Preparaciones de Plantas/farmacología
5.
Molecules ; 23(12)2018 Nov 29.
Artículo en Inglés | MEDLINE | ID: mdl-30501018

RESUMEN

Radix Codonopsis, derived from the roots of Codonopsis pilosula (Franch.) Nannf., Codonopsis pilosula (Franch.) Nannf. Var. modesta (Nannf.) L.T. Shen and Codonopsis tangshen Oliv., has been used as traditional Chinese medicine for improving poor gastrointestinal function, treating gastric ulcers and chronic gastritis in China. Inulin-type fructans are carbohydrates consisting mainly of ß (2→1) fructosyl-fructose links in chemical structure and exhibit a range of properties such as prebiotic activity, fat substitutes in low-calorie foods and disease-modifying effects. The prebiotic effects of inulin-type fructans are hypothesized to improve gastrointestinal function through alterations to gut microbiota composition and metabolism. In the present study, three inulin-type fructans with high degree of polymerization (DP = 16, 22, and 31) were isolated from the roots of Codonopsis pilosula (Franch.) Nannf. and their structures were confirmed by MALDI-TOF-MS, 1D- and 2D-NMR. The prebiotic activity of these fructans was evaluated by detecting growth stimulation on Bifidobacterium longum. The results demonstrated that three fructans at a concentration of 2.0 g/L exhibited significant growth stimulation on Bifidobacterium longum in a time-dependent manner (p < 0.01). The data indicated that inulin-type fructans in Radix Codonopsis could be used as potential prebiotics.


Asunto(s)
Bifidobacterium longum/efectos de los fármacos , Codonopsis/química , Inulina/farmacología , Raíces de Plantas/química , Prebióticos , Bifidobacterium longum/crecimiento & desarrollo , Espectroscopía de Resonancia Magnética con Carbono-13 , Espectroscopía de Protones por Resonancia Magnética , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
6.
Benef Microbes ; 9(6): 937-949, 2018 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-30099893

RESUMEN

The biological effects of three probiotic strains Lactobacillus rhamnosus K32, Bifidobacterium longum GT15, Enterococcus faecium L3 and their mixture were studied using a model of dysbiosis induced in rats by antibiotics. It was found that after taking different probiotics intestinal microbiota changed in a strain-specific manner. The maximal activity against pathogens was revealed after the administration of a mixture of bacterial strains under study or a single strain of enterococci. The strain E. faecium L3 showed the most activity against both Klebsiella spp. and Bacteroides fragilis. It helped to restore the original content of Faecalibacterium prausnitzii. The number of Klebsiella spp. was the same in the group receiving L. rhamnosus K32 and the group of animals, which was not consuming probiotics. Different probiotic strains included in the composition had various immunological effects. Probiotic bifidobacteria, enterococci and the mixture of three probiotics stimulated of mRNA expression of interleukin (IL)-10 in mesenteric lymph nodes. The changes in microbiota after consuming an enterococcal probiotic correlated with an increase in transforming growth factor (TGF)-ß and IL-10 content in blood serum and an increase of the intestinal mucus layer. Consumption of L. rhamnosus K32 led to the stimulation of IL-8 expression in mesenteric lymph nodes. Control group not receiving probiotics was characterised by expression of pro-inflammatory cytokines, damage of epithelial cells and the destruction of their tight junctions. The damage to the ultrastructure of the mucosa was prevented in all the groups taking probiotics.


Asunto(s)
Bifidobacterium longum/inmunología , Disbiosis/terapia , Enterococcus faecium/inmunología , Microbioma Gastrointestinal/efectos de los fármacos , Tracto Gastrointestinal/inmunología , Lacticaseibacillus rhamnosus/inmunología , Probióticos/administración & dosificación , Animales , Bifidobacterium longum/crecimiento & desarrollo , Terapia Biológica/métodos , Modelos Animales de Enfermedad , Disbiosis/inducido químicamente , Enterococcus faecium/crecimiento & desarrollo , Inmunidad Innata , Factores Inmunológicos/sangre , Lacticaseibacillus rhamnosus/crecimiento & desarrollo , Ratas , Resultado del Tratamiento
7.
Nutrients ; 10(3)2018 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-29534465

RESUMEN

Nutritional supplements are popular among athletes to improve performance and physical recovery. Protein supplements fulfill this function by improving performance and increasing muscle mass; however, their effect on other organs or systems is less well known. Diet alterations can induce gut microbiota imbalance, with beneficial or deleterious consequences for the host. To test this, we performed a randomized pilot study in cross-country runners whose diets were complemented with a protein supplement (whey isolate and beef hydrolysate) (n = 12) or maltodextrin (control) (n = 12) for 10 weeks. Microbiota, water content, pH, ammonia, and short-chain fatty acids (SCFAs) were analyzed in fecal samples, whereas malondialdehyde levels (oxidative stress marker) were determined in plasma and urine. Fecal pH, water content, ammonia, and SCFA concentrations did not change, indicating that protein supplementation did not increase the presence of these fermentation-derived metabolites. Similarly, it had no impact on plasma or urine malondialdehyde levels; however, it increased the abundance of the Bacteroidetes phylum and decreased the presence of health-related taxa including Roseburia, Blautia, and Bifidobacterium longum. Thus, long-term protein supplementation may have a negative impact on gut microbiota. Further research is needed to establish the impact of protein supplements on gut microbiota.


Asunto(s)
Atletas , Proteínas en la Dieta/efectos adversos , Suplementos Dietéticos/efectos adversos , Disbiosis/etiología , Microbioma Gastrointestinal , Resistencia Física , Fenómenos Fisiológicos en la Nutrición Deportiva , Adulto , Animales , Bacteroidetes/clasificación , Bacteroidetes/crecimiento & desarrollo , Bacteroidetes/aislamiento & purificación , Bifidobacterium longum/clasificación , Bifidobacterium longum/crecimiento & desarrollo , Bifidobacterium longum/aislamiento & purificación , Biomarcadores/análisis , Biomarcadores/sangre , Biomarcadores/orina , Bovinos , Clostridiales/clasificación , Clostridiales/crecimiento & desarrollo , Clostridiales/aislamiento & purificación , Método Doble Ciego , Disbiosis/sangre , Disbiosis/microbiología , Disbiosis/orina , Heces/química , Heces/microbiología , Humanos , Masculino , Tipificación Molecular , Acondicionamiento Físico Humano , Proyectos Piloto , Hidrolisados de Proteína/efectos adversos , España , Proteína de Suero de Leche/efectos adversos
8.
Mol Nutr Food Res ; 62(7): e1701070, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29453804

RESUMEN

SCOPE: Probiotics may influence one-carbon (C1) metabolism, neurotransmitters, liver function markers, or behavior. METHODS AND RESULTS: Male adult Flinders Sensitive Line rats (model of depression, FSL; n = 22) received Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 (109 or 1010 colony-forming units per day) or vehicle for 10 weeks. The controls, Flinders Resistant Line rats (FRL, n = 8), only received vehicle. C1-related metabolites were measured in plasma, urine, and different tissues. Monoamine concentrations were measured in plasma, hippocampus, and prefrontal cortex. Vehicle-treated FSL rats had higher plasma concentrations of betaine, choline, and dimethylglycine, but lower plasma homocysteine and liver S-adenosylmethionine (SAM) than FRLs. FSL rats receiving high-dose probiotics had lower plasma betaine and higher liver SAM compared to vehicle-treated FSL rats. FSLs had higher concentrations of norepinephrine, dopamine, and serotonin than FRLs across various brain regions. Probiotics decreased plasma dopamine in FSLs in a dose-dependent manner. There were no detectable changes in liver function markers or behavior. CONCLUSIONS: Probiotics reduced the flow of methyl groups via betaine, increased liver SAM, and decreased plasma dopamine and norepinephrine. Since these changes in methylation and catecholamine pathways are known to be involved in several diseases, future investigation of the effect of probiotics is warranted.


Asunto(s)
Antidepresivos/uso terapéutico , Bifidobacterium longum/crecimiento & desarrollo , Depresión/terapia , Hipocampo/metabolismo , Lactobacillus helveticus/crecimiento & desarrollo , Corteza Prefrontal/metabolismo , Probióticos/uso terapéutico , Animales , Antidepresivos/administración & dosificación , Antidepresivos/efectos adversos , Conducta Animal , Biomarcadores/sangre , Biomarcadores/metabolismo , Biomarcadores/orina , Depresión/sangre , Depresión/metabolismo , Depresión/orina , Dopamina/sangre , Dopamina/metabolismo , Antagonistas de Dopamina/administración & dosificación , Antagonistas de Dopamina/efectos adversos , Antagonistas de Dopamina/uso terapéutico , Liofilización , Homocisteína/antagonistas & inhibidores , Homocisteína/sangre , Hígado/metabolismo , Masculino , Metilación , Neuronas/metabolismo , Norepinefrina/antagonistas & inhibidores , Norepinefrina/sangre , Norepinefrina/metabolismo , Probióticos/administración & dosificación , Probióticos/efectos adversos , Distribución Aleatoria , Ratas Mutantes , S-Adenosilmetionina/antagonistas & inhibidores , S-Adenosilmetionina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA